EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sublingual Immunotherapy Decreased the Serum Levels of Interleukin‐36 γ in Allergic Rhinitis

Xiaowei Qin, Chunrui Wang, Jueqi Li, Xiaopeng Zhang, Tianhong Zhang iD

Mediators of Inflammation · 2024

DOI: 10.1155/2024/9692031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, 2024. Verfasst von Xiaowei Qin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Sublingual Immunotherapy, Interleukin-1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allergy immunotherapy (AIT), a treatment approach for allergic rhinitis (AR), is recognized for its potential to modify the disease course beyond mere symptom relief. Interleukin‐36 γ (IL‐36 γ ), a key player in immune responses, has been implicated in promoting eosinophilic inflammation in AR by activating eosinophils. We aimed to investigate the effect of IL‐36 γ on group II lymphoid cell (ILC2) in AR patients who underwent sublingual immunotherapy (SLIT).

Methods

Twenty‐four AR patients were enrolled and administered with SLIT. Serum proteins of IL‐36 γ , interleukin‐5 (IL‐5), and interleukin‐13 (IL‐13) during SLIT were quantitatively assessed using enzyme‐linked immunosorbent assay (ELISA). The proportion of ILC2 was determined by flow cytometry. Sorted ILC2s were stimulated by IL‐36 γ and ILC2 cell differentiation, and type II cytokines expression were examined.

Results

SLIT treatment decreased the serum protein levels of IL‐36 γ , IL‐5, IL‐13, and the proportion of ILC2 significantly. IL‐36 γ suppressed the proliferation of ILC2 by inhibiting the levels of ILC2 transcription factor. IL‐36 γ also inhibited IL‐5 and IL‐13 expression from ILC2.

Conclusion

The changes of IL‐36 γ during SLIT were related to the inhibited function of ILC2, implying that IL‐36 γ may be used as a new biomarker for monitoring the efficacy of SLIT in AR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhinitis, AllergicSublingual ImmunotherapyInterleukin-1HumansFemaleMaleAdultMiddle AgedInterleukin-13Interleukin-5Young AdultFlow CytometryEnzyme-Linked Immunosorbent AssayLymphocytes

Stichwörter der Autor:innen

IL-36γallergic rhinitissublingual immunotherapy

Substanzen

Interleukin-1Interleukin-13Interleukin-5IL36G protein, human

Autor:innen und Institutionen

  • Department of Otolaryngology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.

ORCID-Profile: Tianhong Zhang

Zitieren

APA

Qin, X., Wang, C., Li, J., Zhang, X., & Zhang, T. (2024). Sublingual Immunotherapy Decreased the Serum Levels of Interleukin‐36 γ in Allergic Rhinitis. Mediators of Inflammation. https://doi.org/10.1155/2024/9692031

Vancouver

Qin X, Wang C, Li J, Zhang X, Zhang T. Sublingual Immunotherapy Decreased the Serum Levels of Interleukin‐36 γ in Allergic Rhinitis. Mediators of Inflammation. 2024. doi:10.1155/2024/9692031

BibTeX
@article{Qin2024,
  author = {Qin, Xiaowei and Wang, Chunrui and Li, Jueqi and Zhang, Xiaopeng and Zhang, Tianhong},
  title = {Sublingual Immunotherapy Decreased the Serum Levels of Interleukin‐36 γ in Allergic Rhinitis},
  journal = {Mediators of Inflammation},
  year = {2024},
  doi = {10.1155/2024/9692031}
}
Kostenlos starten →